桂枝茯苓丸治疗IgA肾病  

Guizhi Fuling Pill in Treatment of IgA Nephropathy

在线阅读下载全文

作  者:许济祥 张霞[1,2] 任翎嘉 宋纯东[2] 任献青[1,2] 丁樱[1,2] XU Jixiang;ZHANG Xia;REN Lingjia;SONG Chundong;REN Xianqing;DING Ying(Henan University of Chinese Medicine,Zhengzhou Henan China 450046;The First Affiliated Hospital to Henan University of Chinese Medicine,Zhengzhou Henan China 450000)

机构地区:[1]河南中医药大学,河南郑州450046 [2]河南中医药大学第一附属医院,河南郑州450000

出  处:《中医学报》2025年第3期510-514,共5页Acta Chinese Medicine

基  金:国家自然科学基金面上项目(82474568);河南省科技厅-河南省科技研发计划联合基金项目(222301420078);河南省中青年学科带头人培养项目{豫卫人〔2022〕26号}。

摘  要:IgA肾病以肾小球系膜区免疫球蛋白A沉积伴系膜增生为主要病理特点,部分患者初起可表现为急进性肾炎或肾病综合征,极易进展至慢性肾衰竭。IgA肾病的病理改变属中医癥瘕积聚范畴。《黄帝内经》提出:“积之始生,得寒乃生,厥乃成积也。”认为癥瘕积聚的形成始于肾阳虚衰,阴寒内生,继发气血运行障碍,导致瘀血和痰饮等有形病理产物的形成和裹结。基于此,在临床实践中运用桂枝茯苓丸以温阳化瘀、化气行水,可达到缓消癥积的治疗效果,有助于改善和延缓IgA肾病患者的肾脏病理进展。IgA nephropathy is characterized by immunoglobulin A deposition in the glomerular mesangial area with mesangial hyperplasia,and some of the patients may have acute nephritis or nephrotic syndrome at the beginning of the disease,and it is very easy to progress to chronic renal failure.IgA nephropathy belongs to the category of abdomen mass in traditional Chinese medicine.In Huang Di Nei Jing,it is suggested that"accumulation beginning with Cold injury and existing with injury progression".It is believed that the formation of mass in the abdomen begins with the weakening of Kidney Yang and the birth of inner Cold,which is followed by impaired Qi and blood circulation,resulting in the formation of tangible products of pathologies such as stasis of blood and Phlegm.Based on this,Guizhi Fuling Pill is used in clinical practice to warm Yang,eliminate stasis,resolve Qi and move Water to achieve the therapeutic effect of slowing down and elimination of mass accumulation,which can help to relieve and delay the progression of renal pathology in patients with IgA nephropathy.

关 键 词:IGA肾病 桂枝茯苓丸 “积之始生 得寒乃生” 

分 类 号:R256.59[医药卫生—中医内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象